SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-19-012408
Filing Date
2019-07-10
Accepted
2019-07-10 13:47:16
Documents
4
Period of Report
2019-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K f8k070119a1_heyubiological.htm 8-K/A 36326
2 AMENDED AND RESTATED BYLAWS f8k070119a1ex3-1_heyubio.htm EX-3.1 133593
3 DIRECTOR OFFER LETTER FOR A DIRECTOR WITH MR. BUSCH DATED APRIL 16, 2019 f8k070119a1ex10-1_heyubio.htm EX-10.1 53198
4 DIRECTOR OFFER LETTER FOR AN INDEPENDENT DIRECTOR WITH MR. BUSATLIC DATED APRIL f8k070119a1ex10-2_heyubio.htm EX-10.2 52086
  Complete submission text file 0001213900-19-012408.txt   276694
Mailing Address 4TH FLOOR, NO.10 BUILDING, XINGLIN BAY BUSINESS OPERATION CENTER JIMEI DISTRICT XIAMEN CITY, FUJIAN PROVINCE F4 361022
Business Address 4TH FLOOR, NO.10 BUILDING, XINGLIN BAY BUSINESS OPERATION CENTER JIMEI DISTRICT XIAMEN CITY, FUJIAN PROVINCE F4 361022 86 158 5924 0902
Heyu Biological Technology Corp (Filer) CIK: 0001086303 (see all company filings)

IRS No.: 870627910 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-26731 | Film No.: 19948884
SIC: 7372 Services-Prepackaged Software